THE FIGHT FOR FLIGHT- Chapter One

New Post Public Reply Private Reply Replies (12) Message Board
TheFightforFlight
2,358
THE FIGHT FOR FLIGHT- Chapter One
Understanding the Beginning (1989-2000)

January 9, 2017

Please enjoy the first installment of The Fight for Flight. I welcome all positive and constructive feedback at thefightforflight@gmail.com:

This is the beginning of the story of The Fight for Flight. The untold, unbiased, true story of an airline that over the years has ascended and fallen, only to continue to try to ascend again. It has certainly been a turbulent ride, yet most don’t fully understand the beginning. It is important to understand where something has come from in order to appreciate what it has become and where it is going. “It is darkest before the dawn,” and the dawn is now in sight. However, it was once very dark...

The airline formerly known as “Baltia Air Lines, Inc.” was originally a good idea, however geo-political changes have stark effects on international businesses. Founded in 1989, the goal was to serve the emerging markets of the Baltic States (Latvia, Lithuania, and Estonia) in their continuing efforts to become more fully independent of the Soviet Union. “The Company was incorporated in the State of New York on August 24, 1989, as a United States' airline, with an objective to provide full-service commercial, passenger, cargo and mail transportation from the US to the republics of the former Soviet Union.”*

In 1989, the airline filed for their Air Carrier Certification and applied for route authority to fly to St. Petersburg, Russia. The airline was not unaccompanied in their request. As a result of multiple applications for the route, the DOT initiated a “Route Proceeding” consisting of a special competitive hearing wherein the applicants for the rights to the route participated. After an intense case, specifically the 1990 US-USSR Atlantic Combination Service Case, Docket 47149, in which additional proceedings including an appeal to the Secretary of Transportation took place, Baltia won and was granted route authority (subject to certification) as requested.

As fundraising began, setbacks occurred. “No revenue operations have commenced on authorities granted in 1991 because the Company had not completed financing in 1992. At the time the Company received authority in 1991, the capital markets were slow, the airline industry was in a down-turn, and the USSR was transforming into separate nations, all of which the Company believed limited its access to public or private financing for commencement of flight service. Several of the Company's shareholders who are knowledgeable in financial matters tried to make introductions, but their efforts were useless. Nobody wanted to hear about an airline.”* Nevertheless, positive steps were being taken. At the time a leasing agreement for two Boeing 767-300’s was in effect and the planes were white-tailed pending Baltia operations.

In 1993, following what would be the first challenge of management in the company, certain investors out of Chicago removed Igor Dmitrowsky, the company’s founder and CEO at the time. As a result of the ouster, financing fell through and all startup operations ceased. Igor subsequently regained control and things continued to progress.

In January of 1996, tentative approval for the airline’s operations out of JFK using a Boeing 747 was issued by the DOT. The company at this point was paying little beyond actual out of pocket expenses though as management geared up for the company’s IPO, the airline’s payable account for all of the uncompensated legal work was steadily rising.

It is important to note that the initial IPO fell apart. This was due to the refusal of the then clearing agent, CIBC Oppenheimer Corp. (subsequently, CIBC World Markets) to honor a pre-sold IPO by the broker Hornblower and Weeks. Baltia sued CIBC Oppenheimer Corp. for pulling out at the last minute, however the case was unsuccessful.** In the late 90’s, CIBC (Canadian Imperial Bank of Commerce) was believed to have had concurrent interest in Star Alliance, the airline alliance network then consisting of only five airlines, one being Air Canada. A quote from the book, Straight from the Top: The Truth About Air Canada , by Robert Milton, seems to verify this belief, “Meanwhile, we were kept busy lining up the funding needed to ward off the attack. With pledges of financial support from our Star Alliance partners United Airlines and Lufthansa, I began working to bring CIBC to our side as a critical third source.” ***

At the turn of the century, things would relatively remain the same. It would still be some time before substantial change in management took effect.

To be continued...


Message From the Author:

Precise planning and execution are needed in order for a company to succeed. What we find in business, especially in entrepreneurial ventures, is that many times the founder is unfit to lead it’s company once it is established and in growth phase. There were several points in time, with regard to financing, strategic partnering, and strategic planning, that more thought out and efficient courses of action could have been taken. One could say that Balita, many times, got the short end of the stick. One could also argue, however, how much of that luck is due to the management’s choices? Although the initial management was extremely incompetent at times, the point of this is not to critique, but to understand how the company evolved, or stayed alive, until today. In the next installment, we will cover the second part of the beginning of this airline, building our understanding until we reach what I believe to be the climactic point in this to-be success story under the current management.

Sources:

* SEC '98

** Matter of Balita Air Lines, Inc. v. CIBC Oppenheimer Corp.

*** Straight from the Top: The Truth About Air Canada

Baltia Air Lines Inc (BLTA) Stock Research Links

BLTA Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Updated Category News Views 94

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 5

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
Gentex Shares Tumble Amid Legal Investigation Concerns

Updated Category News Views 10

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Continue Reading
A Game-Changer for Pediatric Diabetes: Novo's Awiqli®

Updated Category News Views 14

Breaking Through the Diabetes Treatment Wall From where I'm sitting, breakthrough approvals like Novo's Awiqli® hit the healthcare landscape with all the subtlety of a freight train. The FDA's green light for Awiqli® as the first once-weekly insulin for kids aged 10 and over with type 2 diabetes is a monumental shift in the treatment paradigm. We're talking about...

Continue Reading
Shanghai and Hamburg Celebrate 40 Years of Collaboration

Updated Category News Views 6

Strengthening the Bond: A Four-Decade Journey With fireworks of diplomacy and cooperation lighting up, Shanghai and Hamburg marked the 40th anniversary of their friendship with an ambition to deepen and broaden ties. These cities, separated by continents but united by their maritime spirit, decided to toast not just the past but also the future. This isn't just some fancy...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 66

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Astra Security Tackles PHP2Shell Vulnerabilities Head-On

Updated Category News Views 26

Unlocking the PHP Puzzle Hot off the press, Astra Security's stepping up to the plate with some freebie tools designed to sniff out and stamp out those pesky PHP2Shell vulnerabilities—CVE-2026-109618 and CVE-2026-109619. If you're not familiar, these suckers rate a whopping 9.2 on the CVSS v4.0 scale, and that means they got the potential to let remote code execution...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 111

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 5

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading